BRAF


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
09 2023
Historique:
medline: 4 9 2023
pubmed: 1 9 2023
entrez: 1 9 2023
Statut: ppublish

Résumé

In-frame

Identifiants

pubmed: 37656784
doi: 10.1126/sciadv.ade7486
doi:

Substances chimiques

naporafenib 15JL80DG6H
Proto-Oncogene Proteins B-raf EC 2.7.11.1
HSP90 Heat-Shock Proteins 0
Amino Acids 0
BRAF protein, human EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eade7486

Auteurs

Manuel Lauinger (M)

Institute of Molecular Medicine, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
Faculty of Biology, University of Freiburg, Freiburg, Germany.

Daniel Christen (D)

Institute of Molecular Medicine, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
Faculty of Biology, University of Freiburg, Freiburg, Germany.
German Cancer Consortium (DKTK), partner site Freiburg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Rhena F U Klar (RFU)

Institute of Molecular Medicine, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
Faculty of Biology, University of Freiburg, Freiburg, Germany.
German Cancer Consortium (DKTK), partner site Freiburg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Freeze-O Organoid Bank, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Department of Internal Medicine I (Hematology, Oncology, and Stem Cell Transplantation), University Hospital of Freiburg, Freiburg, Germany.
Institute of Medical Bioinformatics and Systems Medicine (IBSM), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Carole Roubaty (C)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Christoph E Heilig (CE)

Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.

Michael Stumpe (M)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Jennifer J Knox (JJ)

PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Nikolina Radulovich (N)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Laura Tamblyn (L)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Irene Y Xie (IY)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Peter Horak (P)

Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.

Andrea Forschner (A)

Department of Dermatology, University Hospital of Tübingen, Tübingen, Germany.
German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University, Tübingen, Germany.

Michael Bitzer (M)

German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University, Tübingen, Germany.
Center for Personalized Medicine Tübingen, Eberhard Karls University, Tübingen, Germany.
Department of Internal Medicine I, Eberhard-Karls University, Tübingen, Germany.

Uwe A Wittel (UA)

Department of General and Visceral Surgery, University of Freiburg Medical Center, Faculty of Medicine, 79106 Freiburg, Germany.

Melanie Boerries (M)

German Cancer Consortium (DKTK), partner site Freiburg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Institute of Medical Bioinformatics and Systems Medicine (IBSM), Freiburg University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Comprehensive Cancer Center Freiburg (CCCF), Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.

Claudia R Ball (CR)

Department for Translational Medical Oncology, National Center for Tumor Diseases (NCT/UCC), Dresden, Germany.
German Cancer Research Center (DKFZ), Heidelberg, Germany.
Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
German Cancer Consortium (DKTK), Dresden, Germany.
Technische Universität Dresden, Faculty of Biology, Technische Universität Dresden, Dresden, Germany.

Christoph Heining (C)

Department for Translational Medical Oncology, National Center for Tumor Diseases (NCT/UCC), Dresden, Germany.
German Cancer Research Center (DKFZ), Heidelberg, Germany.
Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
German Cancer Consortium (DKTK), Dresden, Germany.

Hanno Glimm (H)

Department for Translational Medical Oncology, National Center for Tumor Diseases (NCT/UCC), Dresden, Germany.
German Cancer Research Center (DKFZ), Heidelberg, Germany.
Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany.
Translational Medical Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
German Cancer Consortium (DKTK), Dresden, Germany.
Translational Functional Cancer Genomics, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Martina Fröhlich (M)

Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Daniel Hübschmann (D)

German Cancer Consortium (DKTK), Heidelberg, Germany.
Computational Oncology Group, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pattern Recognition and Digital Medicine Group, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), Heidelberg, Germany.

Steven Gallinger (S)

PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Ralph Fritsch (R)

Department of Internal Medicine I (Hematology, Oncology, and Stem Cell Transplantation), University Hospital of Freiburg, Freiburg, Germany.
Department of Medical Oncology and Haematology, University Hospital of Zurich, Zurich, Switzerland.

Stefan Fröhling (S)

Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.

Grainne M O'Kane (GM)

PanCuRx Translational Research Initiative, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Jörn Dengjel (J)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Tilman Brummer (T)

Institute of Molecular Medicine, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
German Cancer Consortium (DKTK), partner site Freiburg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Freeze-O Organoid Bank, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Comprehensive Cancer Center Freiburg (CCCF), Medical Center, Faculty of Medicine, University of Freiburg, 79106 Freiburg, Germany.
Center for Biological Signalling Studies BIOSS, University of Freiburg, 79104 Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH